- Home
- AC vs CBLL Comparison
AC vs CBLL Comparison
Compare AC & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AC
- CBLL
- Stock Information
- Founded
- AC 1976
- CBLL 2014
- Country
- AC United States
- CBLL United States
- Employees
- AC N/A
- CBLL N/A
- Industry
- AC Investment Bankers/Brokers/Service
- CBLL
- Sector
- AC Finance
- CBLL
- Exchange
- AC Nasdaq
- CBLL Nasdaq
- Market Cap
- AC 789.3M
- CBLL 710.2M
- IPO Year
- AC N/A
- CBLL 2024
- Fundamental
- Price
- AC $37.36
- CBLL $18.93
- Analyst Decision
- AC
- CBLL Strong Buy
- Analyst Count
- AC 0
- CBLL 6
- Target Price
- AC N/A
- CBLL $33.00
- AVG Volume (30 Days)
- AC 3.0K
- CBLL 396.6K
- Earning Date
- AC 08-06-2025
- CBLL 08-14-2025
- Dividend Yield
- AC 0.54%
- CBLL N/A
- EPS Growth
- AC 16.36
- CBLL N/A
- EPS
- AC 1.80
- CBLL N/A
- Revenue
- AC $12,293,000.00
- CBLL $71,535,000.00
- Revenue This Year
- AC N/A
- CBLL $34.12
- Revenue Next Year
- AC N/A
- CBLL $28.66
- P/E Ratio
- AC $20.81
- CBLL N/A
- Revenue Growth
- AC N/A
- CBLL 44.86
- 52 Week Low
- AC $28.58
- CBLL $10.01
- 52 Week High
- AC $43.85
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- AC 50.14
- CBLL N/A
- Support Level
- AC $37.21
- CBLL N/A
- Resistance Level
- AC $37.80
- CBLL N/A
- Average True Range (ATR)
- AC 0.48
- CBLL 0.00
- MACD
- AC -0.06
- CBLL 0.00
- Stochastic Oscillator
- AC 23.09
- CBLL 0.00
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.